Nano24 Ltd., a privately held, clinical-stage biotechnology company developing engineered exosome therapeutics, today announced positive results from its randomized, double-blind, placebo-controlled ...
A retrospective dual-database study found that calculated serum osmolality above 300 mOsm/kg before extubation was associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results